{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:27:45Z","timestamp":1767162465162,"version":"build-2238731810"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":1936,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI051731"],"award-info":[{"award-number":["U19AI051731"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/J006742\/1"],"award-info":[{"award-number":["MR\/J006742\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/ajt.14234","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T17:22:46Z","timestamp":1487784166000},"page":"2055-2064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation"],"prefix":"10.1016","volume":"17","author":[{"given":"M.","family":"Manook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kwun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Burghuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Samy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mulvihill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-5235","authenticated-orcid":false,"given":"K.","family":"Freischlag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Curfman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Branum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dorling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mamode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Knechtle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14234_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40560-014-0061-4","article-title":"Complement, thrombotic microangiopathy and disseminated intravascular coagulation","volume":"2","author":"Kurosawa","year":"2014","journal-title":"J Intensive Care"},{"key":"10.1111\/ajt.14234_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.transci.2011.07.002","article-title":"Thrombotic microangiopathy","volume":"45","author":"Mortzell","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"10.1111\/ajt.14234_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijt.2014.11.002","article-title":"Post transplant thrombotic microangiopathy","volume":"8","author":"Rathi","year":"2014","journal-title":"Indian J Transplant"},{"key":"10.1111\/ajt.14234_bib4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/tri.12331","article-title":"An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies","volume":"27","author":"Sreedharanunni","year":"2014","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.14234_bib5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib7","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1053\/j.ajkd.2015.08.009","article-title":"AJKD atlas of renal pathology: Acute antibody-mediated rejection","volume":"66","author":"Najafian","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.14234_bib8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/ajt.13688","article-title":"Antibody mediated rejection in sensitized non-human primates: Modeling human biology","volume":"16","author":"Burghuber","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib9","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1111\/xen.12206","article-title":"Abstracts of the IPITA-IXA-CTS 2015 joint congress November 15\u201319, 2015, Melbourne, Australia","volume":"22","year":"2015","journal-title":"Xenotransplantation"},{"key":"10.1111\/ajt.14234_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.13951","article-title":"Thrombalexins: Cell-localized inhibition of thrombin and its effects in a model of high-risk renal transplantation","volume":"17","author":"Karegli","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2011.07.005","article-title":"Principles and practice of thromboelastography in clinical coagulation management and transfusion practice","volume":"26","author":"Bolliger","year":"2012","journal-title":"Transfus Med Rev"},{"key":"10.1111\/ajt.14234_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/ajcp\/aqv086","article-title":"Pathology consultation on the diagnosis and treatment of thrombotic microangiopathies (TMAs)","volume":"145","author":"Williams","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/ajt.14234_bib13","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/ajt.13688","article-title":"Antibody-mediated rejection in sensitized nonhuman primates: Modeling human biology","volume":"16","author":"Burghuber","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2012-02-412080","article-title":"Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway","volume":"120","author":"Krisinger","year":"2012","journal-title":"Blood"},{"key":"10.1111\/ajt.14234_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13882","article-title":"Splenic irradiation for the treatment of severe antibody-mediated rejection","author":"Orandi","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14234_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.blre.2014.01.003","article-title":"Diagnosis and management of complement mediated thrombotic microangiopathies","volume":"28","author":"Cataland","year":"2014","journal-title":"Blood Rev"},{"key":"10.1111\/ajt.14234_bib18","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib19","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/j.1432-2277.2011.01290.x","article-title":"Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation","volume":"24","author":"Biglarnia","year":"2011","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.14234_bib20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: Outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/lt.24411","article-title":"Possible efficacy of recombinant human soluble thrombomodulin for the treatment of thrombotic microangiopathy after liver transplantation","volume":"22","author":"Ito","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.14234_bib22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/ajt.13647","article-title":"The effects of exogenous administration of human coagulation factors following pig-to-baboon liver xenotransplantation","volume":"16","author":"Navarro-Alvarez","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14234_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/xen.12167","article-title":"Pig-to-baboon heterotopic heart transplantation\u2013exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens","volume":"22","author":"Iwase","year":"2015","journal-title":"Xenotransplantation"},{"key":"10.1111\/ajt.14234_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/xen.12173","article-title":"Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno-immune response","volume":"22","author":"Kim","year":"2015","journal-title":"Xenotransplantation"},{"key":"10.1111\/ajt.14234_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MBC.0b013e32814fcdb8","article-title":"Influence of bivalirudin on tissue factor-triggered coagulation","volume":"18","author":"Butenas","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/ajt.14234_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.humpath.2007.08.012","article-title":"Platelet CD61 expression in vascular calcineurin inhibitor toxicity of renal allografts","volume":"39","author":"Meehan","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1111\/ajt.14234_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: A new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"10.1111\/ajt.14234_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/TP.0000000000000887","article-title":"Hypercoagulability in kidney transplant recipients","volume":"100","author":"Parajuli","year":"2016","journal-title":"Transplantation"}],"updated-by":[{"DOI":"10.1111\/ajt.14501","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000}}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14234","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522250898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522250898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14234\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T11:13:56Z","timestamp":1674386036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522250898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1600613522250898"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14234","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}